Lets review 2022 - BioProcess Insider's Big M&A of the Year!

As the year draws to a close, BioProcess Insider brings you our Christmas quiz special where we test your 2022 M&A knowledge.

Millie Nelson, Editor

December 21, 2022

1 Min Read
Lets review 2022 - BioProcess Insider's Big M&A of the Year!
DepositPhotos/NiroDesign

As the year draws to a close, BioProcess Insider brings you our Christmas quiz special where we test your 2022 M&A knowledge.

2022 has been a year full of M&A activity, some with big price tags and others that have seen companies move into different modalities and service offerings. BioProcess Insider wanted to bring our readers some festive fun ahead of Christmas and the New Year.

Happy Christmas from Bioprocess Insider and here’s to another year full M&A activity!

Loading…

About the Author

Millie Nelson

Millie Nelson

Editor, BioProcess Insider

Journalist covering global biopharmaceutical manufacturing and processing news and host of the Voices of Biotech podcast.

I am currently living and working in London but I grew up in Lincolnshire (UK) and studied in Newcastle (UK).

Got a story? Feel free to email me at [email protected]

See more from Millie Nelson
Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
Subscribe

You May Also Like

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Ask the Expert webcasts
ATE Webcasts
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Latest Content

Get the News

SUBSCRIBE
SUBSCRIBE